Olean General, Bradford Regional enter final steps of merger process

After initially integrating under the umbrella organization Upper Allegheny Health System, Olean (N.Y.) General Hospital and Bradford (Pa.) Regional Medical Center submitted a certificate of need application to officials in New York and Pennsylvania to formally merge.

Advertisement

Officials said in an emailed news release they initially sought a formal merger in 2009, but opted to integrate the health systems under a common parent organization at the recommendation of state officials.

However, after recent discussions with state regulators, the organizations filed a certificate of need application with the New York State Department of Health, the New York State attorney general, the Pennsylvania Department of Health and the Pennsylvania attorney general.

Officials said the merger would create approximately $1.8 million in revenue. The health facilities will remain independent and will continue to provide all clinical services and programs once the merger is complete. Hospital employment, along with the current wage and benefit structures, will also remain intact, the news release states.

The transaction is pending regulatory approval, which officials expect to take approximately one year to complete.

More articles on transactions and valuations:
Walgreens, Susan G. Komen Chicago partner on breast cancer screening initiative
Pennsylvania hospital union issues support for Reading Health System acquisition
Northwestern Medicine in talks to finalize partnership with Centegra Health System

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Transactions & Valuation Issues

Advertisement

Comments are closed.